Recall: International Laboratories, LLC Clopidogrel Tablets USP, 75 Mg
On 2018-01-10, the FDA announced that International Laboratories is conducting a recall on Clopidogrel Tablets USP, 75 Mg due to a possible mislabeling. The recalled products were sold under the brand name(s) International Laboratories and LLC during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 4 drugs recalls due to potential unintended use, including ampicillin and sulbactam for injection usp, dietary supplement and more. Additionally, there have been 9 drug and medical device recalls due to other health hazards as well as 119 food recalls.
Company Contact Information:
Name: International Laboratories
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Clopidogrel Tablets USP, 75 mg
Brand Name(s): International Laboratories, LLC
Reason for Recall: Due to mis-labeling
Official Recall Date: 2018-01-10
Additional information provided by the FDA.gov:
International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg. Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.